Table 5

Clinical characteristics in categorised groups by LV and PV reserve

	Norma LV and PV reserve	Impaired PV and normal LV reserve	Impaired LV and normal PV reserve	Impaired LV and PV reserve
Number	49	36	27	28
Age	57±12	61±12	64±10	63±11
Male, %	5 (10)	6 (17)	1 (4)	2 (7)
Rest echocardiographic variables
LVEDVi, mL/m²	50±10	50±14	48±11	48±9
LVESVi, mL/m²	17±4	17±5	17±4	17±4
LVEF, %	65±4	66±3	64±3	66±4
LVMi, g/m²	76±17	76±15	74±20	74±15
LAVi, mL/m²	27±8	27±10	32±7	29±11
e’, cm/s	11±3	11±3	10±2	10±3
E/e'	6±2	8±3	8±4	7±3
RVEDA, cm²	14±3	15±4	14±3	14±3
RVESA, cm²	8±2	8±2	8±2	8±2
RVFAC, %	44±11	46±9	43±10	44±10
GLS, %	19±2	19±4	19±2	19±3
RVLS, %	24±5	26±6	24±7	25±7
Exercise haemodynamics
Mean PAP, mm Hg	17±2	17±4	18±2	18±3
Mean PAWP, mm Hg	10±2	11±5	12±4	11±4
CO, L/min	3.9±1.1	3.9±1.6	3.7±1.0	3.7±0.9
PVR, wood unit	1.9±0.9	1.8±0.9	1.8±0.8	2.4±1.8
Exercise mean PAP, mm Hg	21±4	24±5*	21±3	26±6*
Exercise mean PAWP, mm Hg	11±3	12±5	15±4*	14±5*
Exercise CO, L/min	7.3±2.5	5.5±1.7*	5.8±1.8*	4.9±0.9*
Exercise PVR, wood unit	1.6±0.6	2.4±0.8*	1.3±0.6	2.7±1.4*
ΔmPAP/ΔCO, mm Hg/L/min	1.6±0.7	5.0±2.0*	1.8±0.7	9.5±6.0*
ΔmPAWP/ΔCO, mm Hg/L/min	0.3±0.2	0.7±0.4	1.5±0.5*	3.0±1.7*
HR for outcomes	Reference	9.9 (1.2–83.1)*	8.4 (1.1–72.8)*	35.4 (4.6–271)*

*Versus normal LV and PV, p<0.05.
CO, cardiac output; e’, early diastolic mitral annular motion; E, early diastolic transmitral flow velocity; LAVi, left atrial volume index; LVEDVi, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVESVi, left ventricular end-systolic volume index; LVMi, left ventricular mass index; mPAP, mean pulmonary artery pressure; mPAWP, mean pulmonary artery wedge pressure; PVR, pulmonary vascular resistance; RVEA, right ventricular end-diastolic area; RVESA, right ventricular end-systolic area; RVFAC, right ventricular functional area change; TAPSE, tricuspid annular plane systolic excursion.